Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial.

J Korean Med Sci · 2012 · PMC3271295 · PMID 22323869

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although it was not statistically significant, the efficacy data in the other outcomes also showed a trend favoring oral solubilized UDCA.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.